Treatment of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma with fludarabine.
Tsatalas
Costas
C
Margaritis
Dimitris
D
Pantelidou
Despina
D
Spanudakis
Emmanuel
E
Kaloutsi
Vasiliki
V
Bourikas
George
G
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006942:Hypergammaglobulinemia; D007119:Immunoblastic Lymphadenopathy / Q000150:complications* / Q000188:drug therapy*; D016399:Lymphoma, T-Cell / Q000150:complications* / Q000188:drug therapy*; D008875:Middle Aged; D012074:Remission Induction; D014740:Vidarabine / Q000031:analogs & derivatives* / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D014740:Vidarabine; C024352:fludarabine